1. Home
  2. PODD vs GWRE Comparison

PODD vs GWRE Comparison

Compare PODD & GWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • GWRE
  • Stock Information
  • Founded
  • PODD 2000
  • GWRE 2001
  • Country
  • PODD United States
  • GWRE United States
  • Employees
  • PODD N/A
  • GWRE N/A
  • Industry
  • PODD Medical/Dental Instruments
  • GWRE Computer Software: Prepackaged Software
  • Sector
  • PODD Health Care
  • GWRE Technology
  • Exchange
  • PODD Nasdaq
  • GWRE Nasdaq
  • Market Cap
  • PODD 16.5B
  • GWRE 15.5B
  • IPO Year
  • PODD 2007
  • GWRE 2012
  • Fundamental
  • Price
  • PODD $261.71
  • GWRE $176.06
  • Analyst Decision
  • PODD Buy
  • GWRE Buy
  • Analyst Count
  • PODD 16
  • GWRE 15
  • Target Price
  • PODD $265.81
  • GWRE $195.71
  • AVG Volume (30 Days)
  • PODD 528.9K
  • GWRE 1.2M
  • Earning Date
  • PODD 11-07-2024
  • GWRE 12-05-2024
  • Dividend Yield
  • PODD N/A
  • GWRE N/A
  • EPS Growth
  • PODD 235.68
  • GWRE N/A
  • EPS
  • PODD 5.74
  • GWRE 0.36
  • Revenue
  • PODD $1,983,900,000.00
  • GWRE $1,035,991,000.00
  • Revenue This Year
  • PODD $23.56
  • GWRE $18.61
  • Revenue Next Year
  • PODD $18.07
  • GWRE $14.70
  • P/E Ratio
  • PODD $45.91
  • GWRE $476.22
  • Revenue Growth
  • PODD 27.42
  • GWRE 12.92
  • 52 Week Low
  • PODD $160.19
  • GWRE $102.66
  • 52 Week High
  • PODD $279.77
  • GWRE $209.15
  • Technical
  • Relative Strength Index (RSI)
  • PODD 46.07
  • GWRE 31.28
  • Support Level
  • PODD $258.96
  • GWRE $168.51
  • Resistance Level
  • PODD $279.77
  • GWRE $174.31
  • Average True Range (ATR)
  • PODD 6.52
  • GWRE 5.15
  • MACD
  • PODD -1.90
  • GWRE -2.76
  • Stochastic Oscillator
  • PODD 4.61
  • GWRE 8.27

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

About GWRE Guidewire Software Inc.

Guidewire Software provides software solutions for property and casualty insurers. Flagship product InsuranceSuite is an on-premises system of record and comprises ClaimCenter, a claims management system; PolicyCenter, a policy management system including policy definitions, quotas, issuance, maintenance, and renewal; and BillingCenter, for billing management, payment plans, and agent commissions. The company also offers InsuranceNow, a cloud-based offering, as well as a variety of other add-on applications.

Share on Social Networks: